Calamine Lotion Bp
Calamine Lotion BP
4.1 Therapeutic indications
For the relief of minor skin rashes and irritation.
Adults, children and elderly
To be applied when required to the affected area.
For topical application.
Hypersensitivity to any of the ingredients.
For external use only.
Keep all medicines out of the reach of children.
No clinically significant interactions known.
May mask x-ray pictures under certain circumstances.
The safety of Calamine Lotion during pregnancy and lactation has not been established but used during these periods is not considered to constitute a hazard.
No adverse effects known.
Occasional hypersensitivity or irritant reactions.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
If ingested symptoms of overdosage include anorexia, nausea, vomiting, epigastric discomfort and diarrhoea. Treatment consists of symptomatic measures only.
Calamine has a mild astringent action on the skin.
There are no preclinical data of relevance to the prescriber which are additional to that already included.
Bentonite Glycerol Sodium Citrate Phenol
A white flint glass bottle with an unlined polypropylene cap.
An amber glass bottle with vinyl seal faced compocork in thermoset plastic cap.
Alternative cap: Aluminium roll-on pilfer proof cap with a flowed in liner or a triseal (LDPE/EPE/LDPE) liner.
Pack sizes: 200, 2000 millilitres.
The Boots Company PLC 1 Thane Road West Nottingham NG2 3AA
Trading as: BCM Almus
Date of First Authorisation: 31 October 1984 Date of Last Renewal: 23 January 1996